A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Mechlorethamine
Nicomorphine
The risk or severity of adverse effects can be increased when Nicomorphine is combined with Pancuronium.
Mechlorethamine
Bezitramide
The risk or severity of adverse effects can be increased when Bezitramide is combined with Pancuronium.
Mechlorethamine
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Pancuronium is combined with Carfentanil, C-11.
Mechlorethamine
Tilidine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Tilidine.
Mechlorethamine
Phenazocine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Phenazocine.
Mechlorethamine
Phenoperidine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Phenoperidine.
Mechlorethamine
Meptazinol
The risk or severity of adverse effects can be increased when Pancuronium is combined with Meptazinol.
Mechlorethamine
Alphaprodine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Alphaprodine.
Mechlorethamine
Piritramide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Piritramide.
Mechlorethamine
Normethadone
The risk or severity of adverse effects can be increased when Pancuronium is combined with Normethadone.
Mechlorethamine
Opium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Opium.
Mechlorethamine
Lofentanil
The risk or severity of adverse effects can be increased when Pancuronium is combined with Lofentanil.
Mechlorethamine
DPDPE
The risk or severity of adverse effects can be increased when Pancuronium is combined with DPDPE.
Mechlorethamine
Ketobemidone
The risk or severity of adverse effects can be increased when Pancuronium is combined with Ketobemidone.
Mechlorethamine
Dihydromorphine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dihydromorphine.
Mechlorethamine
Alphacetylmethadol
The risk or severity of adverse effects can be increased when Pancuronium is combined with Alphacetylmethadol.
Mechlorethamine
Dihydrocodeine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dihydrocodeine.
Mechlorethamine
Carfentanil
The risk or severity of adverse effects can be increased when Pancuronium is combined with Carfentanil.
Mechlorethamine
Dextromoramide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dextromoramide.
Mechlorethamine
Etorphine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Etorphine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3